<DOC>
	<DOCNO>NCT00719758</DOCNO>
	<brief_summary>The purpose study evaluate effect AST-120 PK TRK-100STP , evaluate safety tolerability TRK-100STP alone combination AST-120</brief_summary>
	<brief_title>Drug-Drug Interaction Study TRK-100STP</brief_title>
	<detailed_description>Non-blinded , randomize crossover study evaluate pharmacokinetic interaction TRK-100STP AST-120 different administration condition . Nonelderly adult volunteer receive TRK-100STP without AS-T120 meal . Safety parameter concurrently measure .</detailed_description>
	<mesh_term>Beraprost</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<criteria>Provision write informed consent Body Mass Index ( BMI ) ≥17.6 ≤26.4 kg/m2 weight ≥50 ≤80 kg Clinical abnormal physical finding , include BP , pulse rate , ECG laboratory assessment Receives investigational medicine within 120 day screen Recent blood donor</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>TRK-100STP ,</keyword>
	<keyword>beraprost sodium ,</keyword>
	<keyword>Careload LA</keyword>
	<keyword>AST-120</keyword>
	<keyword>Spherical carbon adsorbent</keyword>
	<keyword>Drug-drug interaction</keyword>
</DOC>